35 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-10.2
rn72cy6bkb 5ck07
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
x3cgnnm
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
23khkuact3wyu 31fkue
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
ec8q ydph
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
d1xuf gpr
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
0ibuskcwg6easnrzsqp
7 Apr 22
Prospectus supplement
4:46pm
S-3
hrgyj4
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
ej50fbw
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
1rz3nej
24 Sep 21
Annual report
7:31am
10-K
8d99k4t31syh8w463
24 Sep 21
Annual report
7:31am
424B3
k63cuawajd8r2120
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-10.1
jhjopu6h57
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am